The company announced that renewal of US FDA inspection of Company’s Bavla facility has been successfully completed on July 08, 2016.
Dishman Pharma and Chemicals Ltd stock was higher by 5% at Rs. 143.The company announced that renewal of US FDA inspection of Company’s Bavla facility has been successfully completed on July 08, 2016.
Dishman Pharma and Chemicals Ltd stock was higher by 5% at Rs. 143.The company announced that renewal of US FDA inspection of Company’s Bavla facility has been successfully completed on July 08, 2016.
The scrip opened at Rs. 148 and has touched a high and low of Rs. 149 and Rs. 143 respectively. So far 454923(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 2196.58 crore.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 209.85 on 04-Nov-2015 and a 52 week low of Rs. 79.78 on 20-Jul-2015. Last one week high and low of the scrip stood at Rs. 144.2 and Rs. 133.75 respectively.
The promoters holding in the company stood at 61.4 % while Institutions and Non-Institutions held 25.21 % and 13.39 % respectively.
The stock is currently trading below its 200 DMA.
No comments:
Post a Comment